Capstone Investment Advisors
RCEL icon

Capstone Investment Advisors’s Avita Medical RCEL Stock Holding History

Capstone Investment Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-13,846
Closed -$257K – 1901
2020
Q4 		$257K Buy
+13,846
New +$304K ﹤0.01% 1411

Other funds holding RCEL

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capstone Investment Advisors's RCEL Position: Q1 2021 in Review

Capstone Investment Advisors sold out of Avita Medical (RCEL) in Q1 2021, closing a stake of 13,846 shares — an estimated $257K sold.

Capstone Investment Advisors first reported a position in RCEL in Q4 2020 and held it in 1 quarter. The position peaked at $257K in Q4 2020. 61 funds tracked by Wall St. Rank hold RCEL as of Q1 2021.

  • Capstone Investment Advisors reported no remaining Avita Medical position as of Q1 2021 after selling out during the quarter.
  • Capstone Investment Advisors sold 13,846 Avita Medical shares in Q1 2021, an estimated $257K.
  • Capstone Investment Advisors first reported a position in Avita Medical in Q4 2020 and held it in 1 quarter.
  • Capstone Investment Advisors's Avita Medical position peaked at $257K in Q4 2020.
  • 61 funds tracked by Wall St. Rank held Avita Medical as of Q1 2021.

Based on Capstone Investment Advisors's 13F filing for Q1 2021, filed 17 May 2021.